Hydroxyflutamide clinical trials
Includes 1 study of 2-Hydroxyflutamide Depot.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2009
How each study uses hydroxyflutamide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Liproca Depot
- 2
Studies by the year they started
3 studies that test it; most in 2009 (1)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2012 | 1 |
| 2017 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Lidds AB (3)
Related medicines
As reviewed, each with the page that says it.
- One of Antiandrogens source
Studies
Open first, then newest update. How each study uses hydroxyflutamide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- A Study to Evaluate the Safety, Tolerability and Efficacy of a Liproca® Depot Injection in Patients With Prostate CancerCompletedPhase 2Lidds ABNCT03348527Written as 2-Hydroxyflutamide Depot
- A Study of 2-hydroxyflutamide (Liproca Depot), Injected Into the Prostate in Patients With Localized Prostate CancerCompletedPhase 2Lidds ABNCT02341404Written as 2-hydroxyflutamide (2-HOF)
- An Efficacy and Safety Study With Licroca Depot, a Controlled Release Product, Injected Into the ProstateCompletedPhase 1/2Lidds ABNCT00913263Written as 2-hydroxyflutamide (2-HOF) [Liproca Depot]
Codes
What other systems call hydroxyflutamide · ClinicalTrials.gg INT002601
- MeSH (NLM) C014290hydroxyflutamideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 31D90UKP5YHYDROXYFLUTAMIDEConfirmed FDA, NLM, Wikidata
- Wikidata Q15633976hydroxyflutamideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C63948HydroxyflutamideOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C014290 | hydroxyflutamide | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 31D90UKP5Y | HYDROXYFLUTAMIDE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q15633976 | hydroxyflutamide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C63948 | Hydroxyflutamide | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.